英国生物银行既往癌症参与者的新发心血管事件与影像表型
本研究基于英国生物银行前瞻性队列,将既往乳腺癌、肺癌、前列腺癌、结直肠癌、子宫癌或血液系统肿瘤的参与者按血管危险因素倾向匹配至无癌症对照,随访11.8±1.7年。竞争风险回归显示,癌症史与新发心血管疾病风险升高及不良心脏重构相关,且独立于共享血管危险因素。
要点
- 血液系统肿瘤与新发心血管病风险升高相关(SHRs: 1.92-3.56)。
- 乳腺癌与特定心血管病风险升高相关(SHRs: 1.34-2.03)。
- 癌症史与不良心脏重构相关,独立于共享血管危险因素。
核心结论
- 癌症史与新发心血管疾病风险升高及不良心脏重构相关,且独立于共享血管危险因素。
研究设计与样本
- 研究纳入英国生物银行中既往乳腺癌、肺癌、前列腺癌、结直肠癌、子宫癌或血液系统肿瘤的参与者,按血管危险因素倾向匹配至无癌症对照,随访11.8±1.7年。
- 采用竞争风险回归计算癌症史与新发心血管病及死亡结局的亚分布风险比(SHR),采用线性回归评估癌症史与左心室和左心房指标的关联。
主要发现
- 血液系统肿瘤与新发所有考虑的心血管病风险升高相关(SHRs: 1.92-3.56),并与更大的心腔容积、更低的射血分数和更差的左心室应变相关。
- 乳腺癌与特定心血管病风险升高相关(非缺血性心肌病、心力衰竭、心包炎和静脉血栓栓塞症;SHRs: 1.34-2.03),并与心力衰竭/非缺血性心肌病死亡、高血压病死亡、更低的左心室射血分数和更低的左心室整体功能指数相关。
- 肺癌与心包炎、心力衰竭和心血管病死亡风险升高相关。
- 前列腺癌与静脉血栓栓塞症风险升高相关。
临床怎么用
- 对既往癌症患者应关注新发心血管病风险,尤其血液系统肿瘤和乳腺癌患者。
- 乳腺癌患者需关注心力衰竭、非缺血性心肌病、心包炎和静脉血栓栓塞症风险。
- 前列腺癌患者需关注静脉血栓栓塞症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate incident cardiovascular outcomes and imaging phenotypes in UK Biobank participants with previous cancer. METHODS: Cancer and cardiovascular disease (CVD) diagnoses were ascertained using health record linkage. Participants with cancer history (breast, lung, prostate, colorectal, uterus, haematological) were propensity matched on vascular risk factors to non-cancer controls. Competing risk regression was used to calculate subdistribution HRs (SHRs) for associations of cancer history with incident CVD (ischaemic heart disease (IHD), non-ischaemic cardiomyopathy (NICM), heart failure (HF), atrial fibrillation/flutter, stroke, pericarditis, venous thromboembolism (VTE)) and mortality outcomes (any CVD, IHD, HF/NICM, stroke, hypertensive disease) over 11.8±1.7 years of prospective follow-up. Linear regression was used to assess associations of cancer history with left ventricular (LV) and left atrial metrics. RESULTS: We studied 18 714 participants (67% women, age: 62 (IQR: 57-66) years, 97% white ethnicities) with cancer history, including 1354 individuals with cardiovascular magnetic resonance. Participants with cancer had high burden of vascular risk factors and prevalent CVDs. Haematological cancer was associated with increased risk of all incident CVDs considered (SHRs: 1.92-3.56), larger chamber volumes, lower ejection fractions, and poorer LV strain. Breast cancer was associated with increased risk of selected CVDs (NICM, HF, pericarditis and VTE; SHRs: 1.34-2.03), HF/NICM death, hypertensive disease death, lower LV ejection fraction, and lower LV global function index. Lung cancer was associated with increased risk of pericarditis, HF, and CVD death. Prostate cancer was linked to increased VTE risk. CONCLUSIONS: Cancer history is linked to increased risk of incident CVDs and adverse cardiac remodelling independent of shared vascular risk factors.
引用
- Raisi-Estabragh Z, Cooper J, McCracken C, et al. Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer. Heart. 2023. PMID: 37072241. doi:10.1136/heartjnl-2022-321888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。